Marc Barry
No Rating Available
(Learn About Our Rating System)

Marc Barry, MD

Languages spoken: English

  • Specialties

    Board Certification

    American Board of Pathology (Sub: Anatomic Path)

  • Board Certification and Academic Information

    Academic Departments Pathology -Primary
    Board Certification
    American Board of Pathology (Sub: Anatomic Path)

    Education history

    Fellowship Urologic Pathology - Brigham and Women's Hospital Fellow
    Cancer Research - Massachusetts Institute of Technology Postdoctoral Research Fellow
    Fellowship Medical Renal Pathology - Brigham and Women's Hospital Fellow
    Harvard Medical School Clinical Fellow
    Residency Anatomic Pathology - Brigham and Women's Hospital Resident
    Pathology - Hospitals affiliated with University College Dublin and Royal College of Surgeons in Ireland House Officer
    Graduate Training Pathology - University College Dublin M.Med.Sci.
    Medicine/Surgery - Mater Misericordiae University Hospital Intern
    Professional Medical Medicine - University College Dublin M.B., B.Ch., BAO

    Selected Publications

    Journal Article

    1. Gan GBerggen K Restrepo Cruz S Hixon M Cowan, A Keysor S Craig S James J Barry M Ozbun M Jimeno A McCance D Beswick E (). MAPKAPK 2 (MK3) inhibition mediates radiation-induced inflammatory cytokine production and tumor growth in head and neck squamous cell carcinoma.  . (Epub ahead of print) Oncogene.
    2. Warde KM, Smith LJ, Liu L, Stubben CJ, Lohman BK, Willett PW, Ammer JL, Castaneda-Hernandez G, Imodoye SO, Zhang C, Jones KD, Converso-Baran K, Ekiz HA, Barry M, Clay MR, Kiseljak-Vassiliades K, Giordano TJ, Hammer GD, Basham KJ (2023). Senescence-induced immune remodeling facilitates metastatic adrenal cancer in a sex-dimorphic manner. Nat Aging, 3(7), 846-865. (Read full article)
    3. Lauer RC, Barry M, Smith TL, Thomas AM, Wu J, Du R, Lee JH, Rao A, Dobroff AS, Arap MA, Nunes DN, Silva IT, Dias-Neto E, Chen I, McCance DJ, Cavenee WK, Pasqualini R, Arap W (2023). Dysregulation of the PRUNE2/PCA3 genetic axis in human prostate cancer: from experimental discovery to validation in two independent patient cohorts. Elife, 12. (Read full article)
    4. Li A, Ambruso SL, Oto OA, Barry M, Edelstein CL (2022). A case report of pre-eclampsia-like endothelial injury in the kidney of an 85-year-old man treated with ibrutinib. BMC Nephrol, 23(1), 264. (Read full article)
    5. Sirohi D, Chipman J, Barry M, Albertson D, Mahlow J, Liu T, Raps E, Haaland B, Sayegh N, Li H, Rathi N, Sharma P, Agarwal N, Knudsen B (2022). Histologic Growth Patterns in Clear Cell Renal Cell Carcinoma Stratify Patients into Survival Risk Groups. Clin Genitourin Cancer, 20(3), e233-e243. (Read full article)
    6. Berggren KL, Restrepo Cruz S, Hixon MD, Cowan AT, Keysar SB, Craig S, James J, Barry M, Ozbun MA, Jimeno A, McCance DJ, Beswick EJ, Gan GN (2019). MAPKAPK2 (MK2) inhibition mediates radiation-induced inflammatory cytokine production and tumor growth in head and neck squamous cell carcinoma. Oncogene, 38(48), 7329-7341. (Read full article)

    Letter

    1. Mahlow J, Sanchez A, Barry M, Sirohi D (2022). Composite pheochromocytoma/paraganglioma-ganglioneuroma with a germline SDHC mutation: a first of its kind case report. [Letter to the editor]. Histopathology, 81(5), 682-685. (Read full article)